Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Phase 1)
Carcinoma, Endometrioid (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Central Nervous System Neoplasms (Phase 1)
Glioblastoma (Early Phase 1)
Glioma (Phase 1)
Lung Neoplasms (Phase 1/Phase 2)
Multiple Myeloma (Phase 1)
Mutation (Phase 1/Phase 2)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Neuroblastoma (Phase 1)
Neurofibroma (Phase 1)
Neurofibroma, Plexiform (Phase 1)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 1)
Thyroid Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue